Psychedelics For The Treatment Of Depression: Focus On 5-HT2A
Dr. Dennis Sholler discusses the topic of psychedelics for the treatment of depression. Dr. Sholler describes the prevalence and burden of depression in the United States. Then, he defines and reviews the history of psychedelics in therapeutic approaches, with a focus on psilocybin. Then, Dr. Sholler reviews the neurobiology of psychedelics, the role of the serotonin (5-HT) 5-HT2A receptor, and results from current psychedelic research. Finally, Dr. Sholler discusses challenges associated with psychedelic-assisted therapies.
Dennis Sholler, PhD, is a Medical Science …